EUVIMEDSkopri EUVIMED
Open access · CC BY 4.0

Dose‐dependent efficacy of a novel dsRNA ‐based solution containing vadescana for Varroa destructor control

Briana E Price, Ryan Kuesel, Taylor Reams, Brian Manley, James Masucci, Brandon K Hopkins

Pest Management Science · 2026-10 · 82 (10) · 9974-9983

DOI: 10.1002/ps.71032 ↗

At a glance

Journal article in Pest Management Science, published online on 2026-06-29. Written by Briana E Price and 5 co-authors. Institution: Department of Entomology, Washington State University, Pullman, WA, USA. Major MEDLINE topics: Varroidae, RNA, Double-Stranded, Pest Control, Biological. Cited 1 times so far (Crossref); 87 references. The full text is freely available (open access, CC BY 4.0). Funded by: Greenlight Biosciences Inc..

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

BACKGROUND A novel dsRNA‐based product, containing a molecule called vadescana, interferes with Varroa destructor (Anderson and Trueman) fecundity and shows promise as a new biopesticide strategy for Varroa management. This study defines optimal dosing rates for vadescana in the field by evaluating efficacy in full‐sized honey bee ( Apis mellifera Linneas) hives to contribute essential preliminary information for vadescana development and implementation. Additionally, this study examined the impacts of various doses of vadescana on colony health by counting frames of bees and brood. RESULTS Various concentrations, application volumes, and regimens (single or split application 3 weeks apart) of vadescana (2, 4, or 8 g/L) were applied to colonies and impacts were compared to colonies left untreated or treated with amitraz (positive control). Vadescana (4 g/L) applied at 4 g per brood box in a single dose was most effective at reducing Varroa populations for up to 18 weeks. Colony populations (average number of frames of bees and brood) remained unaffected among treatments over time. CONCLUSION The results presented provide critical information for the development of vadescana by defining an optimal dose to use in full‐size honey bee colonies and supporting claims of insignificant honey bee colony‐level impacts. This study also introduces further research needs for broader applications and future deployment of this dsRNA‐based Varroa management option. © 2026 The Author(s). Pest Management Science published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry.

Subjects

MeSH terms (MEDLINE)

VarroidaeRNA, Double-StrandedPest Control, BiologicalAnimalsBeesDose-Response Relationship, DrugAcaricides

Author keywords

Apis melliferaRNA interferenceVarroabiopesticidedose–responsevadescana

Substances

RNA, Double-StrandedAcaricides

Authors and institutions

  • Department of Entomology, Washington State University, Pullman, WA, USA.
  • GreenLight Biosciences, Research Triangle Park, Durham, NC, USA.

Funding

  • Greenlight Biosciences Inc.

Cite

APA

Price, B. E., Kuesel, R., Reams, T., Manley, B., Masucci, J., & Hopkins, B. K. (2026). Dose‐dependent efficacy of a novel dsRNA ‐based solution containing vadescana for Varroa destructor control. Pest Management Science, 82(10), 9974-9983. https://doi.org/10.1002/ps.71032

Vancouver

Price BE, Kuesel R, Reams T, Manley B, Masucci J, Hopkins BK. Dose‐dependent efficacy of a novel dsRNA ‐based solution containing vadescana for Varroa destructor control. Pest Management Science. 2026;82(10):9974-9983. doi:10.1002/ps.71032

BibTeX
@article{Price2026,
  author = {Price, Briana E and Kuesel, Ryan and Reams, Taylor and Manley, Brian and Masucci, James and Hopkins, Brandon K},
  title = {Dose‐dependent efficacy of a novel dsRNA ‐based solution containing vadescana for Varroa destructor control},
  journal = {Pest Management Science},
  year = {2026},
  volume = {82},
  number = {10},
  pages = {9974--9983},
  doi = {10.1002/ps.71032}
}
Start for free →